46
Participants
Start Date
May 31, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2028
Radiotherapy
45-50.4Gy in 25-28 fractions to the pelvis on Days 1-5 every week.
Tislelizumab
200 mg IV on Day 1 of each 21-day cycle.
Capecitabine
Capecitabine 1000 mg/m2 orally twice daily (bid) on Day 1 to 14 of each 21-day cycle in CAPOX regimen
Oxaliplatin
130 mg/m2 IV on Day 1 of each 21-day cycle in CAPOX regimen
Capecitabine
825 mg/m2 orally twice daily (bid) 5 days/week during radiotherapy.
Shanghai Zhongshan Hospital
OTHER
Shanghai Changzheng Hospital
OTHER
Huadong Hospital
OTHER
RenJi Hospital
OTHER
Hebei Medical University Fourth Hospital
OTHER
First Hospital of China Medical University
OTHER
Liaoning Cancer Hospital & Institute
OTHER
Fudan University
OTHER